Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Assets (2020 - 2025)

Celularity has reported Current Assets over the past 6 years, most recently at $10.6 million for Q3 2025.

  • Quarterly results put Current Assets at $10.6 million for Q3 2025, down 26.93% from a year ago — trailing twelve months through Sep 2025 was $10.6 million (down 26.93% YoY), and the annual figure for FY2024 was $20.6 million, up 3.88%.
  • Current Assets for Q3 2025 was $10.6 million at Celularity, down from $17.3 million in the prior quarter.
  • Over the last five years, Current Assets for CELU hit a ceiling of $91.3 million in Q3 2021 and a floor of $57811.0 in Q2 2021.
  • Median Current Assets over the past 5 years was $20.6 million (2024), compared with a mean of $31.7 million.
  • Biggest five-year swings in Current Assets: plummeted 92.91% in 2021 and later soared 130416.68% in 2022.
  • Celularity's Current Assets stood at $59.1 million in 2021, then tumbled by 43.31% to $33.5 million in 2022, then plummeted by 40.92% to $19.8 million in 2023, then increased by 3.88% to $20.6 million in 2024, then tumbled by 48.47% to $10.6 million in 2025.
  • The last three reported values for Current Assets were $10.6 million (Q3 2025), $17.3 million (Q2 2025), and $22.1 million (Q1 2025) per Business Quant data.